Confluence Discovery Technologies is a contract research organization (CRO) specializing in early-stage drug discovery, particularly in inflammation and oncology, as a subsidiary of Aclaris Therapeutics. They provide services in medicinal chemistry, biochemistry, and molecular biology.
4340 Duncan Avenue Saint Louis, MO63110 United States
Description
ZoBio is a biotechnology company specializing in fragment-based drug discovery (FBDD), offering services that combine protein engineering, biophysical assays (NMR, SPR), and structural biology to identify small molecule modulators for challenging drug targets.
BioAscent Discovery Ltd is a Contract Research Organization (CRO) specializing in integrated drug discovery and compound management. They provide services including medicinal chemistry and biosciences.
BioCity, Bo'ness Road Newhouse ML1 5UH United Kingdom
Description
Domainex is an integrated drug discovery contract research organization (CRO) founded in 2001, specializing in medicinal chemistry, assay development, and protein science
Chesterford Research Park Saffron Walden CB10 1XL United Kingdom
Description
The Lead Discovery Center (LDC) is a Dortmund, Germany-based translational research organization established in 2008 by Max Planck Innovation. It transforms early-stage academic drug discovery projects into professional pharmaceutical leads for cancer, metabolic, and neurodegenerative diseases.
SpiroChem is a Contract Research Organization (CRO) specializing in drug discovery, medicinal chemistry, and process R&D. They provide services including synthesis, proprietary libraries, and AI-driven computational chemistry.
Edelris is a drug discovery CRO founded in 2005, now part of the Janvier Group. It provides medicinal chemistry, compound libraries (Keymical Space™), and AI-driven screening to pharmaceutical and biotech sectors.
60, Avenue Rockefeller, Bioparc, Bioserra 1 Building 69008Lyon France
Description
Charnwood Discovery (part of Concept Life Sciences) is a UK-based provider of contract drug discovery services, specializing in medicinal chemistry, biology, and ADME/DMPK, ranging from target validation to pre-clinical candidates.
Building 42, Charnwood Campus, 9 Summerpool Road Loughborough LE11 5RD United Kingdom
Description
Genesis Drug Discovery & Development (GD3), part of the Genesis Biotechnology Group, is a contract research organization (CRO) providing end-to-end preclinical services, including medicinal chemistry, biology, DMPK, toxicology, and in vivo pharmacology.
Paraza Pharma is a drug discovery and development services provider. The company offers services in medicinal chemistry, computer-aided drug design (CADD), and chemical development.